Pharmaceutical

Ascendis Pharma files patent for ocular drug delivery s...

Discover Ascendis Pharma's innovative patent for hydrogel prodrug compositions u...

Innate shelves lacutamab monotherapy plans in periphera...

A combo trial will continue as planned in addition to the biotech’s cutaneous T ...

Chinook Therapeutics files patent for improving kidney ...

Discover the groundbreaking patent by Chinook Therapeutics for improving kidney ...

Italfarmaco secures FDA approval for Duchenne muscular ...

The FDA has approved Duvyzat for Duchenne muscular dystrophy patients aged six y...

Lisata clinches rare disease status for osteosarcoma drug

Lisata Therapeutics announced a rare pediatric drug designation for LSTA1, which...

Pharmaceutical drug delivery market and systems

Download our free, comprehensive list of the leading companies within the pharma...

Pharmaceutical consulting companies, pharmaceutical tra...

Download our free list of leading pharmaceutical consulting companies and traini...

Bionomics to advance non-SSRI PTSD candidate to Phase III

Bionomics plans to meet with the FDA following positive topline data from the Ph...

Capstan secures $175m Series B funds for CAR-T therapy

Capstan Therapeutics has secured $175m Series B financing to advance its lead in...

Delivery and manufacturing hurdles remain in the cell a...

Panellists discuss opportunities and challenges in cell and gene therapies at th...

Delivery tech remains challenging with gene therapies f...

Biotech executives discuss why developing gene therapies for central nervous sys...

Merck to invest €300m in South Korean bioprocessing centre

Merck KGaA has announced an investment of over €300m ($326.1m) to establish a ne...

Donanemab: FDA AdCom will put spotlight on tau enrolmen...

Lilly says that the FDA wants to look closer at efficacy implications of the Pha...

Early AMR pipeline looks beyond traditional antibiotics

Different therapeutic approaches against antibiotic-resistant bacteria were high...

Nouscom extends Series C round to $82m for cancer vacci...

Nouscom is part of a cancer vaccine landscape that has recently jump-started fol...

Keytruda combination treatment for NSCLC falls short in...

The Phase III KEYLYNK-006 study evaluating a Keytruda/Lynparza combination treat...